+91-22-48913909
Table of Contents
- മ്യൂച്വൽ ഫണ്ടുകളിൽ ഓൺലൈനിൽ എങ്ങനെ നിക്ഷേപിക്കാം?
- 2022 ലെ മികച്ച 11 മികച്ച മ്യൂച്വൽ ഫണ്ടുകൾ
Top 11 Funds
- DSP BlackRock World Mining Fund
- Nippon India Japan Equity Fund
- ICICI Prudential US Bluechip Equity Fund
- Edelweiss ASEAN Equity Off-shore Fund
- UTI Healthcare Fund
- Franklin Asian Equity Fund
- PGIM India Euro Equity Fund
- SBI Healthcare Opportunities Fund
- Edelweiss Emerging Markets Opportunities Equity Off-shore Fund
- Aditya Birla Sun Life MNC Fund
- HDFC Small Cap Fund
2022-ലെ മികച്ച പ്രകടനം കാഴ്ചവെക്കുന്ന മ്യൂച്വൽ ഫണ്ടുകൾ
ചുവടെയുള്ള മാനദണ്ഡങ്ങൾ അടിസ്ഥാനമാക്കി ഞങ്ങൾ തിരഞ്ഞെടുത്തുമികച്ച പ്രകടനം നടത്തുന്ന മ്യൂച്വൽ ഫണ്ടുകൾ July, 2022. ഞങ്ങൾ ഫിൽട്ടർ ചെയ്‌ത ഫണ്ടുകൾ ഏറ്റവും കുറഞ്ഞത്
100 കോടിഎല്ലാ വിഭാഗങ്ങളിൽ നിന്നും മാനേജ്‌മെന്റിന് കീഴിലുള്ള ആസ്തികൾ.
Talk to our investment specialist
മാനദണ്ഡം
- AUM> 100 കോടി
- ഫണ്ടിന്റെ പ്രായം > 1 വർഷം
- എല്ലാ വിഭാഗങ്ങളിൽ നിന്നുമുള്ള ഫണ്ടുകൾ
- 1 മാസത്തെ റിട്ടേണുകളിൽ ക്രമീകരിച്ചു.
- ഫണ്ടുകളുടെ വിഭാഗങ്ങൾ
- ഇക്വിറ്റി
- കടം
- ഹൈബ്രിഡ്
- സ്വർണ്ണം
- ആഗോള ഫണ്ട്
മ്യൂച്വൽ ഫണ്ടുകളിൽ ഓൺലൈനിൽ എങ്ങനെ നിക്ഷേപിക്കാം?
Fincash.com-ൽ ആജീവനാന്ത സൗജന്യ നിക്ഷേപ അക്കൗണ്ട് തുറക്കുക.
നിങ്ങളുടെ രജിസ്ട്രേഷനും KYC പ്രക്രിയയും പൂർത്തിയാക്കുക
രേഖകൾ അപ്‌ലോഡ് ചെയ്യുക (പാൻ, ആധാർ മുതലായവ).കൂടാതെ, നിങ്ങൾ നിക്ഷേപിക്കാൻ തയ്യാറാണ്!
2022 ലെ മികച്ച 11 മികച്ച മ്യൂച്വൽ ഫണ്ടുകൾ
Fund NAV Net Assets (Cr) Min Investment Min SIP Investment 1 MO (%) 3 MO (%) 6 MO (%) 1 YR (%) 3 YR (%) 5 YR (%) 2024 (%) DSP BlackRock World Mining Fund Growth ₹18.7023
↑ 0.40 ₹130 1,000 500 8.2 15.8 19.5 16.9 12.9 12.5 -8.1 Nippon India Japan Equity Fund Growth ₹21.2821
↑ 0.50 ₹272 5,000 100 7.2 12.5 11.8 13.6 14.6 9 9.3 ICICI Prudential US Bluechip Equity Fund Growth ₹66.35
↑ 0.93 ₹3,113 5,000 100 6.8 18.4 2.5 12.7 15.1 14.4 10.4 Edelweiss ASEAN Equity Off-shore Fund Growth ₹30.162
↑ 0.44 ₹108 5,000 1,000 6.8 11.7 7.1 18.9 10.7 9.1 14.5 UTI Healthcare Fund Growth ₹297.005
↑ 2.08 ₹1,099 5,000 500 6.5 8 9.1 18.2 26.5 22.1 42.9 Franklin Asian Equity Fund Growth ₹31.9155
↑ 0.47 ₹263 5,000 500 6.4 14.6 12.9 14.5 7.9 4.2 14.4 PGIM India Euro Equity Fund Growth ₹17.08
↑ 0.22 ₹257 5,000 1,000 6 15.4 9.1 18.3 11.4 2 20.6 SBI Healthcare Opportunities Fund Growth ₹440.228
↑ 4.21 ₹3,849 5,000 500 5.4 4.1 5 20.3 28.3 23.7 42.2 Edelweiss Emerging Markets Opportunities Equity Off-shore Fund Growth ₹17.7314
↑ 0.26 ₹129 5,000 1,000 5.2 17 15.7 15.5 10.1 4.4 5.9 Aditya Birla Sun Life MNC Fund Growth ₹1,401.06
↑ 5.14 ₹3,775 1,000 1,000 5.2 12.5 9.8 1 14 13.7 17.2 HDFC Small Cap Fund Growth ₹143.569
↑ 0.20 ₹35,781 5,000 300 5.1 13.5 12.1 5 26.3 33.9 20.4 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 23 Jul 25
*ഇതിന്റെ ലിസ്റ്റ് ചുവടെയുണ്ട്മുൻനിര മ്യൂച്വൽ ഫണ്ടുകൾ 2022-ലെ സി.എംആസ്തി >= 100 കോടി
The primary investment objective of the Scheme is to seek capital appreciation by investing predominantly in the units of BlackRock Global Funds – World Mining Fund. The Scheme may, at the discretion of the Investment Manager, also invest in the units of other similar overseas mutual fund schemes, which may
constitute a significant part of its corpus. The Scheme may also invest a certain portion of its corpus in money market securities and/or money market/liquid schemes of DSP BlackRock Mutual Fund, in order to meet liquidity requirements from time to time. DSP BlackRock World Mining Fund is a Equity - Global fund was launched on 29 Dec 09. It is a fund with High risk and has given a Below is the key information for DSP BlackRock World Mining Fund Returns up to 1 year are on The primary investment objective of Reliance Japan Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on the recognized stock exchanges of Japan and the secondary objective is to generate consistent returns by investing in debt and money market securities of India. However, there can be no assurance or guarantee that the investment objective of the scheme will be achieved. Nippon India Japan Equity Fund is a Equity - Global fund was launched on 26 Aug 14. It is a fund with High risk and has given a Below is the key information for Nippon India Japan Equity Fund Returns up to 1 year are on The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities (including ADRs/GDRs issued by Indian and foreign companies) of companies listed on New York Stock Exchange and/or NASDAQ. However, there can be no assurance that the investment objective of the Scheme will be realized. ICICI Prudential US Bluechip Equity Fund is a Equity - Global fund was launched on 6 Jul 12. It is a fund with High risk and has given a Below is the key information for ICICI Prudential US Bluechip Equity Fund Returns up to 1 year are on The primary investment objective of the Scheme is to provide long term capital growth by investing predominantly in JPMorgan Funds – JF ASEAN Equity Fund, an equity fund which invests primarily in companies of countries which are members of the Association of South East Asian Nations (ASEAN). However, there can be no assurance that the investment objective of the Scheme will be realized. Edelweiss ASEAN Equity Off-shore Fund is a Equity - Global fund was launched on 1 Jul 11. It is a fund with High risk and has given a Below is the key information for Edelweiss ASEAN Equity Off-shore Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on An open-end diversified equity fund that seeks to provide medium to long term appreciation through investments primarily in Asian Companies / sectors (excluding Japan) with long term potential across market capitalisation. Franklin Asian Equity Fund is a Equity - Global fund was launched on 16 Jan 08. It is a fund with High risk and has given a Below is the key information for Franklin Asian Equity Fund Returns up to 1 year are on (Erstwhile DHFL Pramerica Top Euroland Offshore Fund) The primary investment objective of the scheme is to generate long-term capital growth from a diversified portfolio of units of overseas mutual funds. PGIM India Euro Equity Fund is a Others - Fund of Fund fund was launched on 11 Sep 07. It is a fund with High risk and has given a Below is the key information for PGIM India Euro Equity Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The primary investment objective of the Scheme is to seek to provide long term capital growth by investing predominantly in the JPMorgan Funds - Emerging Markets Opportunities Fund, an equity fund which invests primarily in an aggressively managed portfolio of emerging market companies Edelweiss Emerging Markets Opportunities Equity Off-shore Fund is a Equity - Global fund was launched on 7 Jul 14. It is a fund with High risk and has given a Below is the key information for Edelweiss Emerging Markets Opportunities Equity Off-shore Fund Returns up to 1 year are on An Open-ended growth scheme with the objective to achieve long-term growth of capital at relatively moderate levels of risk by making investments in securities of multi-national companies through a research based investment approach. Aditya Birla Sun Life MNC Fund is a Equity - Sectoral fund was launched on 27 Dec 99. It is a fund with Moderately High risk and has given a Below is the key information for Aditya Birla Sun Life MNC Fund Returns up to 1 year are on To provide long-term capital appreciation by investing predominantly in Small-Cap and Mid-Cap companies. HDFC Small Cap Fund is a Equity - Small Cap fund was launched on 3 Apr 08. It is a fund with Moderately High risk and has given a Below is the key information for HDFC Small Cap Fund Returns up to 1 year are on 1. DSP BlackRock World Mining Fund
CAGR/Annualized return of 4.1% since its launch. Ranked 19 in Global category. Return for 2024 was -8.1% , 2023 was 0% and 2022 was 12.2% . DSP BlackRock World Mining Fund
Growth Launch Date 29 Dec 09 NAV (23 Jul 25) ₹18.7023 ↑ 0.40 (2.21 %) Net Assets (Cr) ₹130 on 30 Jun 25 Category Equity - Global AMC DSP BlackRock Invmt Managers Pvt. Ltd. Rating ☆☆☆ Risk High Expense Ratio 1.1 Sharpe Ratio 0.06 Information Ratio 0 Alpha Ratio 0 Min Investment 1,000 Min SIP Investment 500 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹15,758 30 Jun 22 ₹14,627 30 Jun 23 ₹17,041 30 Jun 24 ₹17,385 30 Jun 25 ₹18,512 Returns for DSP BlackRock World Mining Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 8.2% 3 Month 15.8% 6 Month 19.5% 1 Year 16.9% 3 Year 12.9% 5 Year 12.5% 10 Year 15 Year Since launch 4.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 -8.1% 2023 0% 2022 12.2% 2021 18% 2020 34.9% 2019 21.5% 2018 -9.4% 2017 21.1% 2016 49.7% 2015 -36% Fund Manager information for DSP BlackRock World Mining Fund
Name Since Tenure Jay Kothari 1 Mar 13 12.34 Yr. Data below for DSP BlackRock World Mining Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Basic Materials 95.17% Energy 1.11% Asset Allocation
Asset Class Value Cash 3.71% Equity 96.27% Debt 0.02% Top Securities Holdings / Portfolio
Name Holding Value Quantity BGF World Mining I2
Investment Fund | -99% ₹126 Cr 202,992
↓ -3,445 Treps / Reverse Repo Investments
CBLO/Reverse Repo | -1% ₹1 Cr Net Receivables/Payables
Net Current Assets | -0% -₹1 Cr 2. Nippon India Japan Equity Fund
CAGR/Annualized return of 7.2% since its launch. Ranked 9 in Global category. Return for 2024 was 9.3% , 2023 was 18.7% and 2022 was -15.3% . Nippon India Japan Equity Fund
Growth Launch Date 26 Aug 14 NAV (24 Jul 25) ₹21.2821 ↑ 0.50 (2.39 %) Net Assets (Cr) ₹272 on 30 Jun 25 Category Equity - Global AMC Nippon Life Asset Management Ltd. Rating ☆☆☆☆ Risk High Expense Ratio 2.44 Sharpe Ratio 0.73 Information Ratio -1.07 Alpha Ratio -3.97 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹12,269 30 Jun 22 ₹9,897 30 Jun 23 ₹11,673 30 Jun 24 ₹12,853 30 Jun 25 ₹14,916 Returns for Nippon India Japan Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 7.2% 3 Month 12.5% 6 Month 11.8% 1 Year 13.6% 3 Year 14.6% 5 Year 9% 10 Year 15 Year Since launch 7.2% Historical performance (Yearly) on absolute basis
Year Returns 2024 9.3% 2023 18.7% 2022 -15.3% 2021 5.7% 2020 2019 2018 2017 2016 2015 Fund Manager information for Nippon India Japan Equity Fund
Name Since Tenure Kinjal Desai 25 May 18 7.1 Yr. Data below for Nippon India Japan Equity Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Industrials 28.78% Consumer Cyclical 16.07% Technology 12.69% Financial Services 12.51% Consumer Defensive 9.92% Communication Services 6.73% Real Estate 6.33% Basic Materials 3.25% Asset Allocation
Asset Class Value Cash 3.72% Equity 96.28% Top Securities Holdings / Portfolio
Name Holding Value Quantity Ajinomoto Co Inc (Consumer Defensive)
Equity, Since 30 Jun 23 | 28024% ₹10 Cr 46,800 BayCurrent Inc (Industrials)
Equity, Since 30 Jun 22 | 65324% ₹10 Cr 21,400 Sumitomo Electric Industries Ltd (Consumer Cyclical)
Equity, Since 30 Jun 24 | 58024% ₹10 Cr 53,900 Nippon Telegraph & Telephone Corp (Communication Services)
Equity, Since 30 Jun 22 | 94323% ₹9 Cr 963,700 Hitachi Ltd (Industrials)
Equity, Since 31 Aug 14 | 65013% ₹9 Cr 38,100 Mitsui & Co Ltd (Industrials)
Equity, Since 30 Jun 24 | MTS13% ₹9 Cr 50,800 Recruit Holdings Co Ltd (Communication Services)
Equity, Since 30 Jun 23 | 60983% ₹9 Cr 17,700 Mitsui Fudosan Co Ltd (Real Estate)
Equity, Since 31 Aug 14 | 88013% ₹9 Cr 110,000 Tokio Marine Holdings Inc (Financial Services)
Equity, Since 30 Jun 22 | MH63% ₹9 Cr 24,900 Sony Group Corp (Technology)
Equity, Since 30 Jun 21 | SON13% ₹9 Cr 39,700 3. ICICI Prudential US Bluechip Equity Fund
CAGR/Annualized return of 15.6% since its launch. Ranked 7 in Global category. Return for 2024 was 10.4% , 2023 was 30.6% and 2022 was -7.1% . ICICI Prudential US Bluechip Equity Fund
Growth Launch Date 6 Jul 12 NAV (23 Jul 25) ₹66.35 ↑ 0.93 (1.42 %) Net Assets (Cr) ₹3,113 on 30 Jun 25 Category Equity - Global AMC ICICI Prudential Asset Management Company Limited Rating ☆☆☆☆ Risk High Expense Ratio 2.18 Sharpe Ratio 0.22 Information Ratio -0.91 Alpha Ratio -6.41 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-3 Months (3%),3-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹13,701 30 Jun 22 ₹12,219 30 Jun 23 ₹15,905 30 Jun 24 ₹17,450 30 Jun 25 ₹19,038 Returns for ICICI Prudential US Bluechip Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 6.8% 3 Month 18.4% 6 Month 2.5% 1 Year 12.7% 3 Year 15.1% 5 Year 14.4% 10 Year 15 Year Since launch 15.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 10.4% 2023 30.6% 2022 -7.1% 2021 22.5% 2020 18.6% 2019 34.3% 2018 5.2% 2017 14.1% 2016 11.6% 2015 0.7% Fund Manager information for ICICI Prudential US Bluechip Equity Fund
Name Since Tenure Ritesh Lunawat 13 Sep 24 0.79 Yr. Sharmila D’mello 1 Jul 22 3 Yr. Nitya Mishra 4 Nov 24 0.65 Yr. Data below for ICICI Prudential US Bluechip Equity Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Health Care 27.21% Technology 21.92% Industrials 13.9% Consumer Defensive 11.93% Financial Services 8.13% Communication Services 5.47% Basic Materials 5.04% Consumer Cyclical 3.86% Energy 0.55% Asset Allocation
Asset Class Value Cash 1.99% Equity 98.01% Top Securities Holdings / Portfolio
Name Holding Value Quantity Veeva Systems Inc Class A (Healthcare)
Equity, Since 31 Oct 21 | VEEV3% ₹92 Cr 38,291 West Pharmaceutical Services Inc (Healthcare)
Equity, Since 31 Dec 24 | WST3% ₹85 Cr 47,000 Huntington Ingalls Industries Inc (Industrials)
Equity, Since 29 Feb 24 | HII3% ₹81 Cr 42,405
↓ -11,786 Brown-Forman Corp Registered Shs -B- Non Vtg (Consumer Defensive)
Equity, Since 30 Jun 24 | BF.B3% ₹80 Cr 281,600 Allegion PLC (Industrials)
Equity, Since 30 Sep 22 | ALLE2% ₹74 Cr 60,986 Zimmer Biomet Holdings Inc (Healthcare)
Equity, Since 31 Mar 17 | ZBH2% ₹74 Cr 93,999
↑ 9,000 Microchip Technology Inc (Technology)
Equity, Since 30 Sep 21 | MCHP2% ₹73 Cr 148,020
↓ -23,000 Pfizer Inc (Healthcare)
Equity, Since 31 Mar 23 | PFE2% ₹73 Cr 362,963 Monolithic Power Systems Inc (Technology)
Equity, Since 31 Dec 24 | MPWR2% ₹73 Cr 12,877
↓ -2,000 Corteva Inc (Basic Materials)
Equity, Since 30 Jun 23 | 2X02% ₹73 Cr 119,840
↓ -28,000 4. Edelweiss ASEAN Equity Off-shore Fund
CAGR/Annualized return of 8.2% since its launch. Ranked 18 in Global category. Return for 2024 was 14.5% , 2023 was -1.4% and 2022 was 4.8% . Edelweiss ASEAN Equity Off-shore Fund
Growth Launch Date 1 Jul 11 NAV (23 Jul 25) ₹30.162 ↑ 0.44 (1.48 %) Net Assets (Cr) ₹108 on 30 Jun 25 Category Equity - Global AMC Edelweiss Asset Management Limited Rating ☆☆☆ Risk High Expense Ratio 1.42 Sharpe Ratio 0.87 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹11,912 30 Jun 22 ₹11,419 30 Jun 23 ₹12,528 30 Jun 24 ₹12,837 30 Jun 25 ₹15,108 Returns for Edelweiss ASEAN Equity Off-shore Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 6.8% 3 Month 11.7% 6 Month 7.1% 1 Year 18.9% 3 Year 10.7% 5 Year 9.1% 10 Year 15 Year Since launch 8.2% Historical performance (Yearly) on absolute basis
Year Returns 2024 14.5% 2023 -1.4% 2022 4.8% 2021 6.3% 2020 2.3% 2019 12% 2018 -2.1% 2017 21.9% 2016 9.6% 2015 -11.1% Fund Manager information for Edelweiss ASEAN Equity Off-shore Fund
Name Since Tenure Bhavesh Jain 27 Sep 19 5.76 Yr. Bharat Lahoti 1 Oct 21 3.75 Yr. Data below for Edelweiss ASEAN Equity Off-shore Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Financial Services 46.2% Consumer Cyclical 11.87% Industrials 9.7% Real Estate 7.94% Communication Services 5.67% Consumer Defensive 4.49% Utility 3.8% Technology 2.84% Health Care 2.79% Energy 1.53% Basic Materials 0.57% Asset Allocation
Asset Class Value Cash 2.59% Equity 97.41% Other 0% Top Securities Holdings / Portfolio
Name Holding Value Quantity JPM ASEAN Equity I (acc) USD
Investment Fund | -98% ₹106 Cr 61,893
↑ 2,770 Clearing Corporation Of India Ltd.
CBLO/Reverse Repo | -1% ₹2 Cr Net Receivables/(Payables)
CBLO | -0% ₹0 Cr Accrued Interest
CBLO/Reverse Repo | -0% ₹0 Cr 5. UTI Healthcare Fund
CAGR/Annualized return of 15.1% since its launch. Ranked 40 in Sectoral category. Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (24 Jul 25) ₹297.005 ↑ 2.08 (0.71 %) Net Assets (Cr) ₹1,099 on 30 Jun 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 0.75 Information Ratio -0.29 Alpha Ratio 1.14 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹15,774 30 Jun 22 ₹13,373 30 Jun 23 ₹15,783 30 Jun 24 ₹22,500 30 Jun 25 ₹27,347 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 6.5% 3 Month 8% 6 Month 9.1% 1 Year 18.2% 3 Year 26.5% 5 Year 22.1% 10 Year 15 Year Since launch 15.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 3.08 Yr. Data below for UTI Healthcare Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Health Care 96.34% Basic Materials 0.99% Asset Allocation
Asset Class Value Cash 2.67% Equity 97.33% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA10% ₹111 Cr 661,016
↓ -11,873 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | CIPLA6% ₹59 Cr 400,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY5% ₹50 Cr 396,000 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL4% ₹46 Cr 80,283
↑ 520 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | AJANTPHARM4% ₹43 Cr 172,829 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | GLENMARK4% ₹40 Cr 275,250 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP4% ₹39 Cr 56,271 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB3% ₹37 Cr 56,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | FORTIS3% ₹33 Cr 465,000 Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | ERIS3% ₹32 Cr 204,451
↓ -8,479 6. Franklin Asian Equity Fund
CAGR/Annualized return of 6.8% since its launch. Ranked 1 in Global category. Return for 2024 was 14.4% , 2023 was 0.7% and 2022 was -14.5% . Franklin Asian Equity Fund
Growth Launch Date 16 Jan 08 NAV (23 Jul 25) ₹31.9155 ↑ 0.47 (1.49 %) Net Assets (Cr) ₹263 on 30 Jun 25 Category Equity - Global AMC Franklin Templeton Asst Mgmt(IND)Pvt Ltd Rating ☆☆☆☆☆ Risk High Expense Ratio 2.5 Sharpe Ratio 0.42 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-3 Years (1%),3 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹13,356 30 Jun 22 ₹10,522 30 Jun 23 ₹10,567 30 Jun 24 ₹11,501 30 Jun 25 ₹12,768 Returns for Franklin Asian Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 6.4% 3 Month 14.6% 6 Month 12.9% 1 Year 14.5% 3 Year 7.9% 5 Year 4.2% 10 Year 15 Year Since launch 6.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 14.4% 2023 0.7% 2022 -14.5% 2021 -5.9% 2020 25.8% 2019 28.2% 2018 -13.6% 2017 35.5% 2016 7.2% 2015 -4.6% Fund Manager information for Franklin Asian Equity Fund
Name Since Tenure Sandeep Manam 18 Oct 21 3.62 Yr. Shyam Sriram 26 Sep 24 0.68 Yr. Data below for Franklin Asian Equity Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Consumer Cyclical 25% Financial Services 23.22% Technology 21% Industrials 6.82% Consumer Defensive 5.07% Communication Services 4.71% Health Care 4.33% Real Estate 2.28% Basic Materials 1.85% Utility 1.38% Asset Allocation
Asset Class Value Cash 4.35% Equity 95.65% Top Securities Holdings / Portfolio
Name Holding Value Quantity Taiwan Semiconductor Manufacturing Co Ltd (Technology)
Equity, Since 31 Mar 09 | 233012% ₹31 Cr 111,000 ICICI Bank Ltd (Financial Services)
Equity, Since 31 Mar 24 | ICICIBANK5% ₹13 Cr 87,497 HDFC Bank Ltd (Financial Services)
Equity, Since 31 Mar 24 | HDFCBANK5% ₹12 Cr 64,250 Tencent Holdings Ltd (Communication Services)
Equity, Since 31 Jul 14 | 007005% ₹12 Cr 21,600 Alibaba Group Holding Ltd Ordinary Shares (Consumer Cyclical)
Equity, Since 31 Dec 20 | 099883% ₹8 Cr 65,204 Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Jul 21 | 5433203% ₹7 Cr 287,506 AIA Group Ltd (Financial Services)
Equity, Since 31 Mar 12 | 012993% ₹7 Cr 95,600 Larsen & Toubro Ltd (Industrials)
Equity, Since 31 Mar 24 | LT3% ₹7 Cr 18,306 Indian Hotels Co Ltd (Consumer Cyclical)
Equity, Since 30 Apr 23 | INDHOTEL3% ₹7 Cr 85,863 HDFC Life Insurance Co Ltd (Financial Services)
Equity, Since 31 Jan 24 | HDFCLIFE3% ₹6 Cr 81,715 7. PGIM India Euro Equity Fund
CAGR/Annualized return of 3% since its launch. Ranked 24 in Fund of Fund category. Return for 2024 was 20.6% , 2023 was 14.6% and 2022 was -35.6% . PGIM India Euro Equity Fund
Growth Launch Date 11 Sep 07 NAV (23 Jul 25) ₹17.08 ↑ 0.22 (1.30 %) Net Assets (Cr) ₹257 on 30 Jun 25 Category Others - Fund of Fund AMC Pramerica Asset Managers Private Limited Rating ☆☆ Risk High Expense Ratio 1.62 Sharpe Ratio 0.65 Information Ratio -0.27 Alpha Ratio 0.36 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹14,340 30 Jun 22 ₹8,625 30 Jun 23 ₹7,889 30 Jun 24 ₹10,090 30 Jun 25 ₹11,528 Returns for PGIM India Euro Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 6% 3 Month 15.4% 6 Month 9.1% 1 Year 18.3% 3 Year 11.4% 5 Year 2% 10 Year 15 Year Since launch 3% Historical performance (Yearly) on absolute basis
Year Returns 2024 20.6% 2023 14.6% 2022 -35.6% 2021 -1.9% 2020 20.5% 2019 21.4% 2018 -10.3% 2017 14.6% 2016 -6.7% 2015 5.7% Fund Manager information for PGIM India Euro Equity Fund
Name Since Tenure Anandha Padmanabhan Anjeneyan 15 Feb 25 0.37 Yr. Vivek Sharma 15 Feb 25 0.37 Yr. Data below for PGIM India Euro Equity Fund as on 30 Jun 25
Asset Allocation
Asset Class Value Cash 3.44% Equity 96.56% Top Securities Holdings / Portfolio
Name Holding Value Quantity PGIM Jennison Emerging Mkts Eq USD W Acc
Investment Fund | -98% ₹154 Cr 166,882
↑ 61,229 Clearing Corporation Of India Ltd.
CBLO/Reverse Repo | -2% ₹3 Cr Net Receivables / (Payables)
Net Current Assets | -0% ₹0 Cr 8. SBI Healthcare Opportunities Fund
CAGR/Annualized return of 15.7% since its launch. Ranked 34 in Sectoral category. Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (23 Jul 25) ₹440.228 ↑ 4.21 (0.97 %) Net Assets (Cr) ₹3,849 on 30 Jun 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 0.87 Information Ratio 0.37 Alpha Ratio 2.79 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹15,902 30 Jun 22 ₹13,774 30 Jun 23 ₹17,755 30 Jun 24 ₹24,634 30 Jun 25 ₹29,799 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 5.4% 3 Month 4.1% 6 Month 5% 1 Year 20.3% 3 Year 28.3% 5 Year 23.7% 10 Year 15 Year Since launch 15.7% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 14.01 Yr. Data below for SBI Healthcare Opportunities Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Health Care 90.06% Basic Materials 6.02% Asset Allocation
Asset Class Value Cash 3.92% Equity 96.08% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA13% ₹470 Cr 2,800,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB7% ₹273 Cr 412,222
↑ 12,222 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH6% ₹236 Cr 2,100,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LZAGY5% ₹178 Cr 300,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | CIPLA5% ₹176 Cr 1,200,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | LUPIN4% ₹164 Cr 840,000 Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND4% ₹138 Cr 560,000 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5433083% ₹123 Cr 1,800,000
↓ -234,372 Fortis Healthcare Ltd (Healthcare)
Equity, Since 30 Apr 21 | FORTIS3% ₹119 Cr 1,680,000 Acutaas Chemicals Ltd (Basic Materials)
Equity, Since 30 Jun 24 | 5433493% ₹118 Cr 1,000,000 9. Edelweiss Emerging Markets Opportunities Equity Off-shore Fund
CAGR/Annualized return of 5.3% since its launch. Ranked 16 in Global category. Return for 2024 was 5.9% , 2023 was 5.5% and 2022 was -16.8% . Edelweiss Emerging Markets Opportunities Equity Off-shore Fund
Growth Launch Date 7 Jul 14 NAV (23 Jul 25) ₹17.7314 ↑ 0.26 (1.47 %) Net Assets (Cr) ₹129 on 30 Jun 25 Category Equity - Global AMC Edelweiss Asset Management Limited Rating ☆☆☆ Risk High Expense Ratio 1.3 Sharpe Ratio 0.45 Information Ratio -1.08 Alpha Ratio -5.29 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹13,614 30 Jun 22 ₹9,848 30 Jun 23 ₹10,354 30 Jun 24 ₹11,500 30 Jun 25 ₹12,858 Returns for Edelweiss Emerging Markets Opportunities Equity Off-shore Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 5.2% 3 Month 17% 6 Month 15.7% 1 Year 15.5% 3 Year 10.1% 5 Year 4.4% 10 Year 15 Year Since launch 5.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 5.9% 2023 5.5% 2022 -16.8% 2021 -5.9% 2020 21.7% 2019 25.1% 2018 -7.2% 2017 30% 2016 9.8% 2015 -14.3% Fund Manager information for Edelweiss Emerging Markets Opportunities Equity Off-shore Fund
Name Since Tenure Bhavesh Jain 9 Apr 18 7.15 Yr. Bharat Lahoti 1 Oct 21 3.67 Yr. Data below for Edelweiss Emerging Markets Opportunities Equity Off-shore Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Financial Services 30.97% Technology 25.38% Consumer Cyclical 20.07% Communication Services 9.8% Energy 3.75% Consumer Defensive 2.94% Industrials 2.86% Real Estate 1.22% Basic Materials 0.79% Health Care 0.62% Asset Allocation
Asset Class Value Cash 1.59% Equity 98.4% Debt 0.01% Top Securities Holdings / Portfolio
Name Holding Value Quantity JPM Emerging Mkts Opps I (acc) USD
Investment Fund | -100% ₹121 Cr 94,772
↓ -570 Clearing Corporation Of India Ltd.
CBLO/Reverse Repo | -0% ₹0 Cr Net Receivables/(Payables)
CBLO | -0% ₹0 Cr Accrued Interest
CBLO/Reverse Repo | -0% ₹0 Cr 10. Aditya Birla Sun Life MNC Fund
CAGR/Annualized return of 15.4% since its launch. Ranked 22 in Sectoral category. Return for 2024 was 17.2% , 2023 was 23.1% and 2022 was -4.8% . Aditya Birla Sun Life MNC Fund
Growth Launch Date 27 Dec 99 NAV (23 Jul 25) ₹1,401.06 ↑ 5.14 (0.37 %) Net Assets (Cr) ₹3,775 on 30 Jun 25 Category Equity - Sectoral AMC Birla Sun Life Asset Management Co Ltd Rating ☆☆☆☆ Risk Moderately High Expense Ratio 2 Sharpe Ratio -0.31 Information Ratio -0.36 Alpha Ratio 1.8 Min Investment 1,000 Min SIP Investment 1,000 Exit Load 0-365 Days (1%),365 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹13,107 30 Jun 22 ₹11,936 30 Jun 23 ₹13,710 30 Jun 24 ₹18,999 30 Jun 25 ₹18,910 Returns for Aditya Birla Sun Life MNC Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 5.2% 3 Month 12.5% 6 Month 9.8% 1 Year 1% 3 Year 14% 5 Year 13.7% 10 Year 15 Year Since launch 15.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 17.2% 2023 23.1% 2022 -4.8% 2021 11.9% 2020 11.6% 2019 4.7% 2018 -4.6% 2017 38% 2016 -3.6% 2015 17.6% Fund Manager information for Aditya Birla Sun Life MNC Fund
Name Since Tenure Chanchal Khandelwal 28 Dec 21 3.43 Yr. Dhaval Joshi 21 Nov 22 2.53 Yr. Data below for Aditya Birla Sun Life MNC Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Consumer Cyclical 26.29% Industrials 18.4% Consumer Defensive 17.49% Health Care 14% Basic Materials 8.85% Financial Services 8.04% Technology 4.48% Asset Allocation
Asset Class Value Cash 1.23% Equity 98.77% Top Securities Holdings / Portfolio
Name Holding Value Quantity Maruti Suzuki India Ltd (Consumer Cyclical)
Equity, Since 31 Mar 09 | MARUTI6% ₹202 Cr 164,321 Schaeffler India Ltd (Consumer Cyclical)
Equity, Since 31 Mar 06 | SCHAEFFLER4% ₹149 Cr 355,403
↓ -2,186 Bayer CropScience Ltd (Basic Materials)
Equity, Since 31 Aug 11 | BAYERCROP4% ₹147 Cr 258,065 United Breweries Ltd (Consumer Defensive)
Equity, Since 31 Jan 22 | UBL4% ₹130 Cr 655,315 Hindustan Unilever Ltd (Consumer Defensive)
Equity, Since 31 Aug 10 | HINDUNILVR3% ₹119 Cr 505,695 Cummins India Ltd (Industrials)
Equity, Since 31 Jan 06 | CUMMINSIND3% ₹117 Cr 357,631 Honeywell Automation India Ltd (Industrials)
Equity, Since 30 Sep 07 | HONAUT3% ₹111 Cr 28,880 ICRA Ltd (Financial Services)
Equity, Since 30 Sep 07 | ICRA3% ₹111 Cr 164,377
↓ -10,000 United Spirits Ltd (Consumer Defensive)
Equity, Since 31 Jan 22 | UNITDSPR3% ₹109 Cr 716,421 GlaxoSmithKline Pharmaceuticals Ltd (Healthcare)
Equity, Since 30 Apr 05 | GLAXO3% ₹105 Cr 317,523
↓ -68,219 11. HDFC Small Cap Fund
CAGR/Annualized return of 16.6% since its launch. Ranked 9 in Small Cap category. Return for 2024 was 20.4% , 2023 was 44.8% and 2022 was 4.6% . HDFC Small Cap Fund
Growth Launch Date 3 Apr 08 NAV (24 Jul 25) ₹143.569 ↑ 0.20 (0.14 %) Net Assets (Cr) ₹35,781 on 30 Jun 25 Category Equity - Small Cap AMC HDFC Asset Management Company Limited Rating ☆☆☆☆ Risk Moderately High Expense Ratio 1.64 Sharpe Ratio 0.07 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 300 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Jun 20 ₹10,000 30 Jun 21 ₹20,663 30 Jun 22 ₹20,250 30 Jun 23 ₹29,345 30 Jun 24 ₹41,471 30 Jun 25 ₹44,032 Returns for HDFC Small Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 23 Jul 25 Duration Returns 1 Month 5.1% 3 Month 13.5% 6 Month 12.1% 1 Year 5% 3 Year 26.3% 5 Year 33.9% 10 Year 15 Year Since launch 16.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 20.4% 2023 44.8% 2022 4.6% 2021 64.9% 2020 20.2% 2019 -9.5% 2018 -8.1% 2017 60.8% 2016 5.4% 2015 6.4% Fund Manager information for HDFC Small Cap Fund
Name Since Tenure Chirag Setalvad 28 Jun 14 10.93 Yr. Dhruv Muchhal 22 Jun 23 1.95 Yr. Data below for HDFC Small Cap Fund as on 30 Jun 25
Equity Sector Allocation
Sector Value Industrials 23.88% Consumer Cyclical 18.3% Technology 14.28% Financial Services 13.4% Health Care 12.17% Basic Materials 7.29% Consumer Defensive 1.88% Communication Services 1.87% Utility 0.35% Asset Allocation
Asset Class Value Cash 6.59% Equity 93.41% Top Securities Holdings / Portfolio
Name Holding Value Quantity Firstsource Solutions Ltd (Technology)
Equity, Since 31 Mar 18 | FSL6% ₹2,023 Cr 54,453,120
↑ 67,853 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 30 Jun 19 | ASTERDM4% ₹1,364 Cr 24,394,493 eClerx Services Ltd (Technology)
Equity, Since 31 Mar 18 | ECLERX4% ₹1,335 Cr 3,769,293 Bank of Baroda (Financial Services)
Equity, Since 31 Mar 19 | BANKBARODA3% ₹1,169 Cr 46,828,792 Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Jul 23 | ERIS3% ₹955 Cr 6,035,882
↑ 61,086 Gabriel India Ltd (Consumer Cyclical)
Equity, Since 31 Oct 18 | GABRIEL2% ₹797 Cr 12,106,772
↑ 1,668 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 31 Jul 23 | 5433082% ₹783 Cr 11,442,105 Power Mech Projects Ltd (Industrials)
Equity, Since 31 Aug 15 | POWERMECH2% ₹767 Cr 2,469,936 Sonata Software Ltd (Technology)
Equity, Since 31 Oct 17 | SONATSOFTW2% ₹743 Cr 18,166,367
↓ -335,332 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Jul 23 | FORTIS2% ₹711 Cr 10,073,132
↓ -1,267,000
ഇവിടെ നൽകിയിരിക്കുന്ന വിവരങ്ങൾ കൃത്യമാണെന്ന് ഉറപ്പാക്കാൻ എല്ലാ ശ്രമങ്ങളും നടത്തിയിട്ടുണ്ട്. എന്നിരുന്നാലും, ഡാറ്റയുടെ കൃത്യത സംബന്ധിച്ച് യാതൊരു ഉറപ്പും നൽകുന്നില്ല. എന്തെങ്കിലും നിക്ഷേപം നടത്തുന്നതിന് മുമ്പ് സ്കീം വിവര രേഖ ഉപയോഗിച്ച് പരിശോധിക്കുക.
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved